8-38417331-G-T
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM2PP2PP3_StrongPP5_Very_Strong
The NM_023110.3(FGFR1):c.1638C>A(p.Asn546Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_023110.3 missense
Scores
Clinical Significance
Conservation
Publications
- encephalocraniocutaneous lipomatosisInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Hartsfield-Bixler-Demyer syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, ClinGen
- hypogonadotropic hypogonadism 2 with or without anosmiaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- osteoglophonic dysplasiaInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Pfeiffer syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- Pfeiffer syndrome type 1Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Jackson-Weiss syndromeInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- hypogonadotropic hypogonadismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated trigonocephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Kallmann syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- septooptic dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- tooth agenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- holoprosencephalyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FGFR1 | NM_023110.3 | c.1638C>A | p.Asn546Lys | missense_variant | Exon 12 of 18 | ENST00000447712.7 | NP_075598.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FGFR1 | ENST00000447712.7 | c.1638C>A | p.Asn546Lys | missense_variant | Exon 12 of 18 | 1 | NM_023110.3 | ENSP00000400162.2 | ||
| FGFR1 | ENST00000397091.9 | c.1632C>A | p.Asn544Lys | missense_variant | Exon 12 of 18 | 1 | ENSP00000380280.5 | |||
| FGFR1 | ENST00000397108.8 | c.1632C>A | p.Asn544Lys | missense_variant | Exon 13 of 19 | 1 | ENSP00000380297.4 | |||
| FGFR1 | ENST00000397113.6 | c.1632C>A | p.Asn544Lys | missense_variant | Exon 12 of 18 | 2 | ENSP00000380302.2 | |||
| FGFR1 | ENST00000356207.9 | c.1371C>A | p.Asn457Lys | missense_variant | Exon 11 of 17 | 1 | ENSP00000348537.5 | |||
| FGFR1 | ENST00000397103.5 | c.1371C>A | p.Asn457Lys | missense_variant | Exon 10 of 16 | 5 | ENSP00000380292.1 | |||
| FGFR1 | ENST00000326324.10 | c.1365C>A | p.Asn455Lys | missense_variant | Exon 11 of 17 | 1 | ENSP00000327229.6 | |||
| FGFR1 | ENST00000487647.5 | n.*1329C>A | non_coding_transcript_exon_variant | Exon 11 of 12 | 1 | ENSP00000435254.1 | ||||
| FGFR1 | ENST00000487647.5 | n.*1329C>A | 3_prime_UTR_variant | Exon 11 of 12 | 1 | ENSP00000435254.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Encephalocraniocutaneous lipomatosis Pathogenic:4Other:1
- -
An FGFR1 c.1638C>A (p.Asn546Lys) variant was identified at an allelic fraction consistent with somatic origin. This variant occurs at a mutational hotspot and has been reported in numerous individuals with encephalocraniocutaneous lipomatosis (Kupsik M et al., PMID: 23819449; Nowaczyk MJ et al., PMID: 10766980; Bennett JT et al., PMID: 26942290; Kordacka J et al., PMID: 31173478; Chacon-Camacho OF et al., PMID: 30891959; Liu J et al., PMID: 31856217). This variant is absent from the general population (gnomAD v.4.1.0), indicating it is not a common variant. It has been reported as a somatic pathogenic variant in the ClinVar database by two submitters (ClinVar ID: 224896) and has been identified in numerous cancer cases, mainly CNS tumors, in the cancer database COSMIC (COSV58329537). Computational predictors indicate that the variant is damaging, evidence that correlates with impact to FGFR1 function. In support of this prediction, functional studies show that over-expression of the FGFR1 p.Asn546Lys protein results in higher nuclear localization compared to wild-type protein, increased cellular invasion and cologenicity, and failure to respond to inhibitory treatments through activation of ERK, STAT3 and AKT pathways (Cimmino F et al., PMID: 35488346; Agelopoulos K et al., PMID: 26179511; Jones DT et al., PMID: 23817572; Ng PK et al., PMID: 29533785). Based on available information and an internally developed protocol informed by the ACMG/AMP guidelines for variant interpretation and gene-specific practices from the ClinGen Criteria Specification Registry (Leon-Quintero FZ et al., PMID: 39434542), the FGFR1 c.1638C>A (p.Asn546Lys) variant is classified as pathogenic. -
- -
- -
- -
Rosette-forming glioneuronal tumor Pathogenic:1
- -
Neoplasm Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at